Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atopic Conjunctivitis”

191 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 191 results

Post-approval studies (Phase 4)Study completedNCT01203540
What this trial is testing

Evaluation of the Effect and Tolerance of Preservative Free NAAGA on the Inflammatory Component and Symptoms of Dry Eye Syndrome in Allergic Conjunctivitis Patients

Who this might be right for
Allergic Conjunctivitis
Laboratoires Thea 21
Testing effectiveness (Phase 2)Study completedNCT01275105
What this trial is testing

A Single-Center, Randomized, Double-Masked, Placebo and Active Controlled, Dose-Ranging Evaluation of the Duration of Action of Brimonidine Tartrate Ophthalmic Solution in the Control of Ocular Redness Induced by Conjunctival Allergen Challenge (CAC)

Who this might be right for
Allergic Conjunctivitis
Eye Therapies, LLC 68
Early research (Phase 1)Study completedNCT02148744
What this trial is testing

Safety and Tolerability of XmAb®7195 in Adult Healthy Volunteers and Adult Subjects With a History of Allergic Rhinitis and/or Allergic Conjunctivitis and/or Atopic Dermatitis

Who this might be right for
Allergic RhinitisAllergic ConjunctivitisAtopic Dermatitis
Xencor, Inc. 72
Not applicableStudy completedNCT01339507
What this trial is testing

A Patient Reported Ocular Comfort Assessment Comparing Bepreve to Lastacaft

Who this might be right for
Allergic Conjunctivitis
Cunningham, Derek N., O.D., P.A. 25
Post-approval studies (Phase 4)Study completedNCT06800274
What this trial is testing

Clinical and Biological Evaluation of NAAGA Versus Azelastine Eye Drops in Allergic Subjects With Tear Film Dysfunction

Who this might be right for
Allergic ConjunctivitisDry Eye Disease (DED)
Azienda Ospedaliera OO.RR. S. Giovanni di Dio e Ruggi D'Aragona 134
Post-approval studies (Phase 4)Study completedNCT01437982
What this trial is testing

Evaluate the Safety and Efficacy of Lotemax Ophthalmic Suspension 0.5%

Who this might be right for
Conjunctivitis, Seasonal AllergicConjunctivitis, Giant PapillaryInflammation
Bausch & Lomb Incorporated 140
Large-scale testing (Phase 3)Study completedNCT04207736
What this trial is testing

The INVIGORATE Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis.

Who this might be right for
Allergic Conjunctivitis
Aldeyra Therapeutics, Inc. 95
Post-approval studies (Phase 4)Study completedNCT02251613
What this trial is testing

Effectiveness of Olopatadine HCl Ophthalmic Solution for the Treatment of Allergic Conjunctivitis in Japan

Who this might be right for
Allergic Conjunctivitis
Alcon Research 50
Post-approval studies (Phase 4)UnknownNCT01390961
What this trial is testing

Comparison of Tolerability Between Two Allergy Drops

Who this might be right for
Allergic Conjunctivitis
Hom, Milton M., OD, FAAO 48
Testing effectiveness (Phase 2)Study completedNCT01001091
What this trial is testing

AL-38583 Ophthalmic Solution for Allergic Conjunctivitis Associated Inflammation

Who this might be right for
Allergic Conjunctivitis
Alcon Research 312
Not applicableStudy completedNCT01342601
What this trial is testing

Safety and Efficacy of Ectoin Allergy Nasal Spray and Ectoin Allergy Eye Drops in the Treatment of Seasonal Allergic Rhinitis (SAR) in Children and Adolescents

Who this might be right for
Seasonal Allergic RhinitisSeasonal Allergic Conjunctivitis
Bitop AG 72
Not applicableUnknownNCT04066998
What this trial is testing

Cytokine Profile of Conjunctivitis, Performed Through Tears Analysis Among Patients Treated With Dupilumab

Who this might be right for
Conjunctival DiseasesAtopic DermatitisSide Effect
Centre Hospitalier Universitaire de Besancon 15
Large-scale testing (Phase 3)Study completedNCT01731249
What this trial is testing

Efficacy and Safety Study of a Sublingual Immunotherapy Solution to Treat Patients Suffering From Birch Pollen Allergic Rhinoconjunctivitis

Who this might be right for
HypersensitivityAllergic RhinitisAllergic Conjunctivitis+1 more
Stallergenes Greer 574
Not applicableStudy completedNCT01471184
What this trial is testing

The Effects of Ectoin® Allergy Nasal Spray and Ectoin® Allergy Eye Drops Compared to Placebo

Who this might be right for
Allergic RhinitisAllergic Conjunctivitis
Bitop AG 46
Large-scale testing (Phase 3)Study completedNCT01551056
What this trial is testing

A Multi-Center Study Evaluating the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle in the Conjunctival Allergen Challenge (CAC)

Who this might be right for
Allergic Conjunctivitis
Aciex Therapeutics, Inc. 91
Early research (Phase 1)Ended earlyNCT03038971
What this trial is testing

Study Evaluating Safety of Ragweed Mix Given by Intralymphatic Node Injections

Who this might be right for
Allergic ConjunctivitisAllergic Rhinitis
Woodmont Pharmaceuticals, Inc. 2
Not applicableStudy completedNCT01686048
What this trial is testing

The Significance of Ambrosia in Allergic Rhinitis and Asthma in Israel

Who this might be right for
Allergic RhinitisAsthmaAllergic Conjunctivitis+1 more
Meir Medical Center 120
Not applicableStudy completedNCT05682976
What this trial is testing

Ophthalmological Adverse Events of Tralokinumab in AD

Who this might be right for
Atopic Dermatitis
Nantes University Hospital 100
Large-scale testing (Phase 3)Study completedNCT02445326
What this trial is testing

OTX-14-007: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis

Who this might be right for
Chronic Allergic Conjunctivitis
Ocular Therapeutix, Inc. 73
Post-approval studies (Phase 4)Study completedNCT05314621
What this trial is testing

A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Flonase® Allergy Relief in Subjects With Allergic Conjunctivitis

Who this might be right for
Allergic Conjunctivitis
Andover Research Eye Institute 61
Load More Results